Explorium Logo

MeiraGTx Holdings plc logo

meiragtx.com

430 East 29th Street, New York, 10016, US

MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

MeiraGTx Holdings plc logo

MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

meiragtx.com

430 East 29th Street, New York, 10016, US

Details

Year founded

2015

Revenue

10M-25M

Employees

201-500

Number of locations

3

NAICS

325413

SIC

2836

Products & Services

Outlines the company's specialized services and operational strengths.

  • Gene therapy treatments
  • Contact us in order to access

Equipment

Provides a detailed list of machinery and tools utilized on the company's premises.

  • Cell expansion suites
  • Bulk production virus suites
  • Downstream purification suites
  • Contact us in order to access

Ramping up production

Indicates the company's current production trend and growth trajectory.

TRUE

Our production algorithm is showing that meiragtx holdings plc is ramping up production.

Target industries

Medical

Employees working in MeiraGTx Holdings plc

Zandy Forbes

President and chief executive officer

Richard Giroux

Chief operating officer

Robert Zeldin

Chief medical officer

Grace Collins

Human resources business partner

Sarah Jeeves

Human resources business partner - uk

Employees working in MeiraGTx Holdings plc

Zandy Forbes

President and chief executive officer

Richard Giroux

Chief operating officer

Robert Zeldin

Chief medical officer

Grace Collins

Human resources business partner

Sarah Jeeves

Human resources business partner - uk

Jun Liu

Vice president, biostatistics

Michael Chang

Vice president, assistant general counsel

News

Yahoo Finance

MeiraGTx Holdings plc (NASDAQ:MGTX): Is Breakeven Near?

Yahoo Finance

MeiraGTx Holdings plc (NASDAQ:MGTX): Is Breakeven Near?

MeiraGTx Holdings is bordering on breakeven, according to the 3 American Biotechs analysts. They anticipate the company to incur a final loss in 2024, before...

Book a demo

Locations (3)

HQ

MeiraGTx Holdings plc

430 East 29th Street, New York, 10016, US

Meiragtx

britannia walk, london n1 7ng

MeiraGTx Netherlands b.v.

Paalbergweg 2, 1105 AG Amsterdam, Netherlands

Frequently Asked Questions


MeiraGTx Holdings plc offers a range of services and capabilities, including Gene therapy treatments.


Get the full services & capabilities list of MeiraGTx Holdings plc

MeiraGTx Holdings plc uses a variety of equipment, including Cell expansion suites.


Get the full equipment list of MeiraGTx Holdings plc

MeiraGTx Holdings plc serves several industries, including the medical industry.


Get the full target industries list of MeiraGTx Holdings plc

MeiraGTx Holdings plc operates from 3 locations.


Get a free locations and target markets review for MeiraGTx Holdings plc

MeiraGTx Holdings plc's revenue is $15.92M.


Get a free financial data review of MeiraGTx Holdings plc

The headquarters of MeiraGTx Holdings plc are located in 430 east 29th street, new york, new york 10016, united states.


Get a free locations and target markets review for MeiraGTx Holdings plc

The NAICS code for MeiraGTx Holdings plc is 325413.


Get a free business data review for MeiraGTx Holdings plc

MeiraGTx Holdings plc has 358 employees.


Get a free workforce data review of MeiraGTx Holdings plc

The official website of MeiraGTx Holdings plc is https://www.meiragtx.com.


MeiraGTx Holdings plc was founded in 2015.